Australia Infant Phototherapy Device Market Forecast 2025–2033
Description
Australia Infant Phototherapy Device Market Size and Forecast 2025-2033
Australia Infant Phototherapy Device Market is estimated to reach US$ 2.47 billion by 2033, from US$ 1.88 billion in 2024, growing at a CAGR of 3.1% during 2025-2033. This is supported by an increase in cases of neonatal jaundice, increase in awareness about early infant health care, and advances in non-invasive phototherapy treatments in hospitals and neonatal intensive care units in the country.
Australia Infant Phototherapy Device Market Outlooks
Infant phototherapy equipment is a medical device employed to treat neonatal jaundice, a prevalent condition in infants characterized by high bilirubin levels in the blood. The devices release blue light waves (usually 460–490 nm) that facilitate the breakdown of excess bilirubin so that it may be excreted from the infant's body. The therapy is safe, non-invasive, and very effective when applied promptly.
In Australia, infant phototherapy equipment usage is common and fully integrated into neonatal service, particularly in maternity wards and hospitals. As a result of the excellent level of healthcare, early screening procedures, and increased awareness among parents, phototherapy demand has increased. LED-based phototherapy units are commonly utilized by hospitals, as they are more energy efficient and produce less heat, posing less risk and being more comfortable for infants. The Australian government's emphasis on better neonatal outcomes, and higher birth rates in some areas, continues to propel the adoption of sophisticated phototherapy solutions throughout Australia.
Growth Drivers in Australia Infant Phototherapy Device Market
Increasing Prevalence of Neonatal Jaundice
Neonatal jaundice is a common disorder in newborns throughout Australia, frequently due to premature birth or immaturity of the liver. Early detection and treatment are prioritized by hospitals and clinics to avert complications such as kernicterus. With more babies being screened on birth, the demand for phototherapy devices is increasing. The higher rate of diagnosis, coupled with increased parental and caregiver awareness, accelerates the demand for effective and non-invasive treatment devices. KPMG reviewed recent Australian Bureau of Statistics figures, a total of 289,100 births in Australia for 2023.
Advances in Phototherapy Devices Technology
The market is experiencing innovation in phototherapy equipment, such as the application of LED technology, fiber-optic phototherapy blankets, and sophisticated intensity controls. These advances provide improved treatment results, energy efficiency, portability, and infant comfort. Australian hospitals are spending more on such innovations, fueling market growth. The replacement of fluorescent-based with LED-based equipment is particularly significant in urban and rural health facilities. In March 2022, Cook Medical launched The MINC+ Benchtop Incubator for clinical embryologists and IVF clinics across Australia. This kind of product launches is anticipated to drive prenatal care in the country, anticipated to drive market growth over the forecast period.
Government Support and Healthcare Infrastructure
Australia's strong public healthcare system, as well as government interventions in neonatal and maternal health, largely facilitate the implementation of infant phototherapy equipment. Public and private hospital procurement inclusion, in addition to funding of rural healthcare outreach, fuel broad access. Programs for training healthcare personnel also ensure proper usage, enhancing results and building trust in their effectiveness nationwide.
Challenges in the Australia Infant Phototherapy Device Market
Expensive Equipment and Budget Restraints
With the advantages, the cost of advanced phototherapy equipment—particularly LED-based equipment—is a challenge for small clinics and rural hospitals. Budget constraints can result in underuse or the use of outdated machines. The absence of centralized procurement regulations in certain regions is also a factor in uneven distribution and late upgrades in lower-income or remote areas.
Limited Availability in Remote and Indigenous Populations
Healthcare access geographic disparities continue to be a significant issue. Remote and Indigenous populations in Australia might not have direct access to neonatal units or phototherapy equipment. Transporting the newborns to larger centers for treatment can create a delay in receiving it and exposes them to greater chances of complications. This gap has to be filled by investing in mobile phototherapy technology and trained staff to cover underserved populations.
Australia Infant Phototherapy Fluorescent Lamps Device Market
Phototherapy devices based on fluorescent lamps were previously the norm in neonatal wards. Although cheaper than LED-based options, they are hotter running and need frequent bulb replacement, raising maintenance costs. Although being phased out in urban areas over time, they still find use in rural or lower-cost institutions. Increasing demand for safer and more efficient units will, however, constrain the growth of this segment.
Australia Infant Phototherapy Mobile Device Market
Mobile phototherapy devices provide convenience and are best suited for application in neonatal units where space is scarce or for rural outreach programs. They can be moved conveniently between rooms or institutions, and their use is essential in out-of-the-way places. Portability also assists in home-care settings under supervision. The need for mobile solutions keeps on growing with attempts to decentralize Australia's neonatal care.
Australia Infant Phototherapy Fixed Device Market
Fixed phototherapy units are a staple in larger hospitals, providing high-intensity treatment with stability. They are typically installed in NICUs and maternity wards and are suitable for high-volume patient environments. These systems are known for durability and consistent output, but their immobility limits use in flexible care settings. Hospitals with established neonatal departments often prefer these systems for round-the-clock usage.
Australia Infant Phototherapy Device Hospital Market
Hospitals continue to be the largest consumers of infant phototherapy devices based on the number of births and availability of NICUs. Public and private hospitals in Australia give utmost importance to upgrading neonatal equipment, including high-intensity low-heat phototherapy systems. Incorporation of such devices into neonatal policy helps in early intervention as well as better outcomes. Government health subsidies and procurement assistance enable growth of this market segment.
Victoria Infant Phototherapy Device Market
Victoria, with its high concentration of urban dwellers and robust healthcare system, accounts for a high proportion of the phototherapy device market. Principal cities such as Melbourne have well-developed hospitals and neonatal centers that continuously invest in the most recent technology. Public health programs directed at maternal and child health also contribute to consistent demand in both metropolitan and regional hospitals in the state.
Queensland Infant Phototherapy Device Market
Queensland's vast geography necessitates access to neonatal treatment as an imperative both in urban and rural regions. While the larger cities like Brisbane accommodate sophisticated pediatric facilities, there is immense need for phototherapy machines. Even doctors in the countryside are increasingly utilizing mobile as well as LED-based units to enhance patient access to care. Government health departments remain involved in funding and outreach activities.
Tasmania Infant Phototherapy Device Market
Tasmania, although less populated, has a high level of healthcare. Both Hobart and Launceston have well-equipped hospitals with latest phototherapy equipment, and smaller clinics use the advantage of mobile units for treating newborn jaundice in their areas. The state government also funds rural outreach services encompassing neonatal screening and treatment facilities, helping to create a consistent market for fixed and mobile phototherapy equipment.
Western Australia Infant Phototherapy Device Market
Western Australia's immense and far-flung terrain presents logistical complications in neonatal care. Perthan hospitals are highly equipped, but every attempt to extend care to outlying Aboriginal communities is made. Mobile and compact phototherapy equipment is increasingly being sent into remote areas to fill gaps in the continuum of care. The state's focus on maternal health services and rural outreach supports demand for convenient, effective treatment devices.
Market Segmentation
Light Source
• Fluorescent Lamps
• Light Emitting Diodes
• Quartz Halogen Lamps
• Gas Discharge Tubes
Configuration
• Mobile Device
• Fixed Device
End User
• Hospital
• Neonatal Clinics
Top States
• New South Wales
• Victoria
• Queensland
• Western Australia
• South Australia
• Australian Capital Territory
• Tasmania
• Northern Territory
All companies have been covered with 5 Viewpoints
• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis
Key Players Analysis
• Ningbo David Medical Device Co., Ltd
• Koninklijke Philips N.V.
• General Electric Company
• Inapiration Healthcare Group Plc
• Drägerwerk AG & Co. KGaA
• Ibis Medical Equipment and Systems Pvt Ltd
• Weyer GmbH
• Natus Medical Incorporated
Australia Infant Phototherapy Device Market is estimated to reach US$ 2.47 billion by 2033, from US$ 1.88 billion in 2024, growing at a CAGR of 3.1% during 2025-2033. This is supported by an increase in cases of neonatal jaundice, increase in awareness about early infant health care, and advances in non-invasive phototherapy treatments in hospitals and neonatal intensive care units in the country.
Australia Infant Phototherapy Device Market Outlooks
Infant phototherapy equipment is a medical device employed to treat neonatal jaundice, a prevalent condition in infants characterized by high bilirubin levels in the blood. The devices release blue light waves (usually 460–490 nm) that facilitate the breakdown of excess bilirubin so that it may be excreted from the infant's body. The therapy is safe, non-invasive, and very effective when applied promptly.
In Australia, infant phototherapy equipment usage is common and fully integrated into neonatal service, particularly in maternity wards and hospitals. As a result of the excellent level of healthcare, early screening procedures, and increased awareness among parents, phototherapy demand has increased. LED-based phototherapy units are commonly utilized by hospitals, as they are more energy efficient and produce less heat, posing less risk and being more comfortable for infants. The Australian government's emphasis on better neonatal outcomes, and higher birth rates in some areas, continues to propel the adoption of sophisticated phototherapy solutions throughout Australia.
Growth Drivers in Australia Infant Phototherapy Device Market
Increasing Prevalence of Neonatal Jaundice
Neonatal jaundice is a common disorder in newborns throughout Australia, frequently due to premature birth or immaturity of the liver. Early detection and treatment are prioritized by hospitals and clinics to avert complications such as kernicterus. With more babies being screened on birth, the demand for phototherapy devices is increasing. The higher rate of diagnosis, coupled with increased parental and caregiver awareness, accelerates the demand for effective and non-invasive treatment devices. KPMG reviewed recent Australian Bureau of Statistics figures, a total of 289,100 births in Australia for 2023.
Advances in Phototherapy Devices Technology
The market is experiencing innovation in phototherapy equipment, such as the application of LED technology, fiber-optic phototherapy blankets, and sophisticated intensity controls. These advances provide improved treatment results, energy efficiency, portability, and infant comfort. Australian hospitals are spending more on such innovations, fueling market growth. The replacement of fluorescent-based with LED-based equipment is particularly significant in urban and rural health facilities. In March 2022, Cook Medical launched The MINC+ Benchtop Incubator for clinical embryologists and IVF clinics across Australia. This kind of product launches is anticipated to drive prenatal care in the country, anticipated to drive market growth over the forecast period.
Government Support and Healthcare Infrastructure
Australia's strong public healthcare system, as well as government interventions in neonatal and maternal health, largely facilitate the implementation of infant phototherapy equipment. Public and private hospital procurement inclusion, in addition to funding of rural healthcare outreach, fuel broad access. Programs for training healthcare personnel also ensure proper usage, enhancing results and building trust in their effectiveness nationwide.
Challenges in the Australia Infant Phototherapy Device Market
Expensive Equipment and Budget Restraints
With the advantages, the cost of advanced phototherapy equipment—particularly LED-based equipment—is a challenge for small clinics and rural hospitals. Budget constraints can result in underuse or the use of outdated machines. The absence of centralized procurement regulations in certain regions is also a factor in uneven distribution and late upgrades in lower-income or remote areas.
Limited Availability in Remote and Indigenous Populations
Healthcare access geographic disparities continue to be a significant issue. Remote and Indigenous populations in Australia might not have direct access to neonatal units or phototherapy equipment. Transporting the newborns to larger centers for treatment can create a delay in receiving it and exposes them to greater chances of complications. This gap has to be filled by investing in mobile phototherapy technology and trained staff to cover underserved populations.
Australia Infant Phototherapy Fluorescent Lamps Device Market
Phototherapy devices based on fluorescent lamps were previously the norm in neonatal wards. Although cheaper than LED-based options, they are hotter running and need frequent bulb replacement, raising maintenance costs. Although being phased out in urban areas over time, they still find use in rural or lower-cost institutions. Increasing demand for safer and more efficient units will, however, constrain the growth of this segment.
Australia Infant Phototherapy Mobile Device Market
Mobile phototherapy devices provide convenience and are best suited for application in neonatal units where space is scarce or for rural outreach programs. They can be moved conveniently between rooms or institutions, and their use is essential in out-of-the-way places. Portability also assists in home-care settings under supervision. The need for mobile solutions keeps on growing with attempts to decentralize Australia's neonatal care.
Australia Infant Phototherapy Fixed Device Market
Fixed phototherapy units are a staple in larger hospitals, providing high-intensity treatment with stability. They are typically installed in NICUs and maternity wards and are suitable for high-volume patient environments. These systems are known for durability and consistent output, but their immobility limits use in flexible care settings. Hospitals with established neonatal departments often prefer these systems for round-the-clock usage.
Australia Infant Phototherapy Device Hospital Market
Hospitals continue to be the largest consumers of infant phototherapy devices based on the number of births and availability of NICUs. Public and private hospitals in Australia give utmost importance to upgrading neonatal equipment, including high-intensity low-heat phototherapy systems. Incorporation of such devices into neonatal policy helps in early intervention as well as better outcomes. Government health subsidies and procurement assistance enable growth of this market segment.
Victoria Infant Phototherapy Device Market
Victoria, with its high concentration of urban dwellers and robust healthcare system, accounts for a high proportion of the phototherapy device market. Principal cities such as Melbourne have well-developed hospitals and neonatal centers that continuously invest in the most recent technology. Public health programs directed at maternal and child health also contribute to consistent demand in both metropolitan and regional hospitals in the state.
Queensland Infant Phototherapy Device Market
Queensland's vast geography necessitates access to neonatal treatment as an imperative both in urban and rural regions. While the larger cities like Brisbane accommodate sophisticated pediatric facilities, there is immense need for phototherapy machines. Even doctors in the countryside are increasingly utilizing mobile as well as LED-based units to enhance patient access to care. Government health departments remain involved in funding and outreach activities.
Tasmania Infant Phototherapy Device Market
Tasmania, although less populated, has a high level of healthcare. Both Hobart and Launceston have well-equipped hospitals with latest phototherapy equipment, and smaller clinics use the advantage of mobile units for treating newborn jaundice in their areas. The state government also funds rural outreach services encompassing neonatal screening and treatment facilities, helping to create a consistent market for fixed and mobile phototherapy equipment.
Western Australia Infant Phototherapy Device Market
Western Australia's immense and far-flung terrain presents logistical complications in neonatal care. Perthan hospitals are highly equipped, but every attempt to extend care to outlying Aboriginal communities is made. Mobile and compact phototherapy equipment is increasingly being sent into remote areas to fill gaps in the continuum of care. The state's focus on maternal health services and rural outreach supports demand for convenient, effective treatment devices.
Market Segmentation
Light Source
• Fluorescent Lamps
• Light Emitting Diodes
• Quartz Halogen Lamps
• Gas Discharge Tubes
Configuration
• Mobile Device
• Fixed Device
End User
• Hospital
• Neonatal Clinics
Top States
• New South Wales
• Victoria
• Queensland
• Western Australia
• South Australia
• Australian Capital Territory
• Tasmania
• Northern Territory
All companies have been covered with 5 Viewpoints
• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis
Key Players Analysis
• Ningbo David Medical Device Co., Ltd
• Koninklijke Philips N.V.
• General Electric Company
• Inapiration Healthcare Group Plc
• Drägerwerk AG & Co. KGaA
• Ibis Medical Equipment and Systems Pvt Ltd
• Weyer GmbH
• Natus Medical Incorporated
Table of Contents
200 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
